학술논문
Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak.
Document Type
Article
Author
Kohn, Milena; Alsuliman, Tamim; Lamure, Sylvain; Cheminant, Morgane; Delage, Jéremy; Merle De Boever, Corinne; Tudesq, Jean Jacques; Marjanovic, Zora; Van de Wyngaert, Zoé; Malard, Florent; Brissot, Eolia; Rigaudeau, Sophie; Marque-Juillet, Stéphanie; Therby, Audrey; Cartron, Guillaume; Rousselot, Philippe; Hermine, Olivier; Duléry, Rémy; Besson, Caroline
Source
Subject
*CHRONIC lymphocytic leukemia
*SARS-CoV-2 Omicron variant
*CHRONIC leukemia
*SARS-CoV-2
*BRUTON tyrosine kinase
*DIFFUSE large B-cell lymphomas
*
*
*
*
*
Language
ISSN
1042-8194
Abstract
Predominant malignancies were diffuse large B-cell lymphoma (13 patients, 21%), CLL (11 patients, 17%) and follicular lymphoma (10 patients, 16%). Patients who had been hospitalized due to COVID-19 (hospitalized patients) were compared to other patients according to their initial characteristics (Supplementary methods 2). In the international EPICOVIDEHA survey run during 2020 when wild-type SARS-CoV-2 was dominant, 29% of CLL patients and 56% of non-Hodgkin lymphoma patients had severe or critical infection and 28% and 30% died, respectively [[2]]. Since the outbreak of SARS-CoV-2, patients with a history of cancer [[1]], especially those with hematological malignancies [[2]] were shown to be at high risk of severe COVID-19. [Extracted from the article]